1. Home
  2. HAE vs PBH Comparison

HAE vs PBH Comparison

Compare HAE & PBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HAE
  • PBH
  • Stock Information
  • Founded
  • HAE 1971
  • PBH 1996
  • Country
  • HAE United States
  • PBH United States
  • Employees
  • HAE N/A
  • PBH N/A
  • Industry
  • HAE Medical/Dental Instruments
  • PBH Biotechnology: Pharmaceutical Preparations
  • Sector
  • HAE Health Care
  • PBH Health Care
  • Exchange
  • HAE Nasdaq
  • PBH Nasdaq
  • Market Cap
  • HAE 4.4B
  • PBH 4.1B
  • IPO Year
  • HAE 1991
  • PBH 2005
  • Fundamental
  • Price
  • HAE $81.56
  • PBH $79.90
  • Analyst Decision
  • HAE Strong Buy
  • PBH Strong Buy
  • Analyst Count
  • HAE 9
  • PBH 3
  • Target Price
  • HAE $108.78
  • PBH $83.67
  • AVG Volume (30 Days)
  • HAE 494.4K
  • PBH 251.5K
  • Earning Date
  • HAE 02-06-2025
  • PBH 02-06-2025
  • Dividend Yield
  • HAE N/A
  • PBH N/A
  • EPS Growth
  • HAE N/A
  • PBH N/A
  • EPS
  • HAE 2.41
  • PBH 4.10
  • Revenue
  • HAE $1,361,223,000.00
  • PBH $1,110,659,000.00
  • Revenue This Year
  • HAE $7.63
  • PBH $1.66
  • Revenue Next Year
  • HAE $4.40
  • PBH $2.27
  • P/E Ratio
  • HAE $33.82
  • PBH $20.00
  • Revenue Growth
  • HAE 9.84
  • PBH N/A
  • 52 Week Low
  • HAE $70.25
  • PBH $57.95
  • 52 Week High
  • HAE $97.97
  • PBH $86.36
  • Technical
  • Relative Strength Index (RSI)
  • HAE 44.19
  • PBH 43.14
  • Support Level
  • HAE $80.65
  • PBH $80.26
  • Resistance Level
  • HAE $83.32
  • PBH $84.98
  • Average True Range (ATR)
  • HAE 2.13
  • PBH 1.70
  • MACD
  • HAE -0.63
  • PBH -0.85
  • Stochastic Oscillator
  • HAE 11.31
  • PBH 4.90

About HAE Haemonetics Corporation

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company places primary emphasis on its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.

About PBH Prestige Consumer Healthcare Inc.

Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.

Share on Social Networks: